These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Metformin and gut microbiota: their interactions and their impact on diabetes. Vallianou NG, Stratigou T, Tsagarakis S. Hormones (Athens); 2019 Jun; 18(2):141-144. PubMed ID: 30719628 [Abstract] [Full Text] [Related]
9. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin. Zhang C, Ma S, Wu J, Luo L, Qiao S, Li R, Xu W, Wang N, Zhao B, Wang X, Zhang Y, Wang X. Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839 [Abstract] [Full Text] [Related]
11. The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities. Brunkwall L, Orho-Melander M. Diabetologia; 2017 Jun; 60(6):943-951. PubMed ID: 28434033 [Abstract] [Full Text] [Related]
12. Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study. Bryrup T, Thomsen CW, Kern T, Allin KH, Brandslund I, Jørgensen NR, Vestergaard H, Hansen T, Hansen TH, Pedersen O, Nielsen T. Diabetologia; 2019 Jun; 62(6):1024-1035. PubMed ID: 30904939 [Abstract] [Full Text] [Related]
13. Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats. Zhang M, Feng R, Yang M, Qian C, Wang Z, Liu W, Ma J. BMJ Open Diabetes Res Care; 2019 Jun; 7(1):e000717. PubMed ID: 31641523 [Abstract] [Full Text] [Related]
14. Changes in the type 2 diabetes gut mycobiome associate with metformin treatment across populations. Van Syoc E, Nixon MP, Silverman JD, Luo Y, Gonzalez FJ, Elbere I, Klovins J, Patterson AD, Rogers CJ, Ganda E. mBio; 2024 Jun 12; 15(6):e0016924. PubMed ID: 38767350 [Abstract] [Full Text] [Related]
17. Response of gut microbiota in type 2 diabetes to hypoglycemic agents. Zhang F, Wang M, Yang J, Xu Q, Liang C, Chen B, Zhang J, Yang Y, Wang H, Shang Y, Wang Y, Mu X, Zhu D, Zhang C, Yao M, Zhang L. Endocrine; 2019 Dec 12; 66(3):485-493. PubMed ID: 31410749 [Abstract] [Full Text] [Related]
18. Combined effects of Scutellaria baicalensis with metformin on glucose tolerance of patients with type 2 diabetes via gut microbiota modulation. Shin NR, Gu N, Choi HS, Kim H. Am J Physiol Endocrinol Metab; 2020 Jan 01; 318(1):E52-E61. PubMed ID: 31770016 [Abstract] [Full Text] [Related]
19. Considering gut microbiota in treatment of type 2 diabetes mellitus. Adeshirlarijaney A, Gewirtz AT. Gut Microbes; 2020 May 03; 11(3):253-264. PubMed ID: 32005089 [Abstract] [Full Text] [Related]
20. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Wu H, Esteve E, Tremaroli V, Khan MT, Caesar R, Mannerås-Holm L, Ståhlman M, Olsson LM, Serino M, Planas-Fèlix M, Xifra G, Mercader JM, Torrents D, Burcelin R, Ricart W, Perkins R, Fernàndez-Real JM, Bäckhed F. Nat Med; 2017 Jul 03; 23(7):850-858. PubMed ID: 28530702 [Abstract] [Full Text] [Related] Page: [Next] [New Search]